Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 647

1.

Evolution of Geographic Atrophy in Participants Treated with Ranibizumab for Neovascular Age-related Macular Degeneration.

Thavikulwat AT, Jacobs-El N, Kim JS, Agrón E, Hasan J, Meyerle CB, Valent D, Cukras CA, Wiley HE, Wong WT, Chew EY.

Ophthalmol Retina. 2017 Jan-Feb;1(1):34-41. doi: 10.1016/j.oret.2016.09.005.

PMID:
28630947
2.

Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation.

McGill TJ, Bohana-Kashtan O, Stoddard JW, Andrews MD, Pandit N, Rosenberg-Belmaker LR, Wiser O, Matzrafi L, Banin E, Reubinoff B, Netzer N, Irving C.

Transl Vis Sci Technol. 2017 Jun 14;6(3):17. doi: 10.1167/tvst.6.3.17. eCollection 2017 Jun.

3.

Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice.

Prasad T, Zhu P, Verma A, Chakrabarty P, Rosario AM, Golde TE, Li Q.

Sci Rep. 2017 Jun 12;7(1):3222. doi: 10.1038/s41598-017-03397-2.

4.

Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases.

Yamaguchi M, Nakao S, Arima M, Wada I, Kaizu Y, Hao F, Yoshida S, Sonoda KH.

J Ophthalmol. 2017;2017:8543592. doi: 10.1155/2017/8543592. Epub 2017 May 10. Review.

5.

Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology.

Sun S, Li Z, Glencer P, Cai B, Zhang X, Yang J, Li X.

Stem Cell Res Ther. 2017 Jun 6;8(1):135. doi: 10.1186/s13287-017-0584-4. Review.

6.

Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration.

Cotrim CC, Toscano L, Messias A, Jorge R, Siqueira RC.

Clin Ophthalmol. 2017 May 19;11:931-938. doi: 10.2147/OPTH.S133502. eCollection 2017.

7.

Simultaneous dexamethasone intravitreal implant and anti-VEGF therapy for neovascular age-related macular degeneration resistant to anti-VEGF monotherapy.

Todorich B, Thanos A, Yonekawa Y, Mane G, Hasbrook M, Thomas BJ, Woodward MA, Williams GA, Capone A Jr, Wolfe JD, Faia LJ, Hassan TS.

J Vitreoretin Dis. 2017;1(1):65-74. doi: 10.1177/2474126416683299. Epub 2017 Jan 26.

8.

Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide.

Uehara H, Muddana SK, Zhang X, Das SK, Bhuvanagiri S, Liu J, Wu Y, Choi S, Carroll LS, Archer B, Ambati BK.

Transl Vis Sci Technol. 2017 May 24;6(3):9. doi: 10.1167/tvst.6.3.9. eCollection 2017 May.

9.

The complexities underlying age-related macular degeneration: could amyloid beta play an important role?

Lynn SA, Keeling E, Munday R, Gabha G, Griffiths H, Lotery AJ, Ratnayaka JA.

Neural Regen Res. 2017 Apr;12(4):538-548. doi: 10.4103/1673-5374.205083. Review.

10.

Extracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cells.

Fields MA, Bowrey HE, Gong J, Moreira EF, Cai H, Del Priore LV.

PLoS One. 2017 May 15;12(5):e0177763. doi: 10.1371/journal.pone.0177763. eCollection 2017.

11.

Dietary intake of α-linolenic acid and risk of age-related macular degeneration.

Wu J, Cho E, Giovannucci EL, Rosner BA, Sastry SM, Schaumberg DA, Willett WC.

Am J Clin Nutr. 2017 Jun;105(6):1483-1492. doi: 10.3945/ajcn.116.143453. Epub 2017 May 3.

PMID:
28468892
12.

Effects of Age-Related Macular Degeneration on Postural Sway.

Chatard H, Tepenier L, Jankowski O, Aussems A, Allieta A, Beydoun T, Salah S, Bucci MP.

Front Hum Neurosci. 2017 Mar 31;11:158. doi: 10.3389/fnhum.2017.00158. eCollection 2017.

13.

Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.

Wittenborn JS, Clemons T, Regillo C, Rayess N, Liffmann Kruger D, Rein D.

JAMA Ophthalmol. 2017 May 1;135(5):452-459. doi: 10.1001/jamaophthalmol.2017.0255.

PMID:
28358948
14.

Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits.

Grassmann F, Kiel C, Zimmermann ME, Gorski M, Grassmann V, Stark K; International AMD Genomics Consortium (IAMDGC), Heid IM, Weber BH.

Genome Med. 2017 Mar 27;9(1):29. doi: 10.1186/s13073-017-0418-0.

15.

New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.

Schnabolk G, Beon MK, Tomlinson S, Rohrer B.

J Ocul Pharmacol Ther. 2017 Jun;33(5):400-411. doi: 10.1089/jop.2016.0101. Epub 2017 Mar 23.

PMID:
28333572
16.

Cell Therapy for Age-Related Macular Degeneration: A New Vision for the Bone Marrow?

Ljubimov AV.

Mol Ther. 2017 Apr 5;25(4):832-833. doi: 10.1016/j.ymthe.2017.03.004. Epub 2017 Mar 15. No abstract available.

PMID:
28318930
17.

The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.

Brown GC, Brown MM, Lieske HB, Turpcu A, Rajput Y.

Int J Retina Vitreous. 2017 Feb 13;3:5. doi: 10.1186/s40942-016-0058-3. eCollection 2017.

18.

Characterization of the human aqueous humour proteome: A comparison of the genders.

Perumal N, Manicam C, Steinicke M, Funke S, Pfeiffer N, Grus FH.

PLoS One. 2017 Mar 8;12(3):e0172481. doi: 10.1371/journal.pone.0172481. eCollection 2017.

19.

Surgery for cataracts in people with age-related macular degeneration.

Casparis H, Lindsley K, Kuo IC, Sikder S, Bressler NM.

Cochrane Database Syst Rev. 2017 Feb 16;2:CD006757. doi: 10.1002/14651858.CD006757.pub4. Review.

PMID:
28206671
20.

Systemic Injection of RPE65-Programmed Bone Marrow-Derived Cells Prevents Progression of Chronic Retinal Degeneration.

Qi X, Pay SL, Yan Y, Thomas J Jr, Lewin AS, Chang LJ, Grant MB, Boulton ME.

Mol Ther. 2017 Apr 5;25(4):917-927. doi: 10.1016/j.ymthe.2017.01.015. Epub 2017 Feb 13.

Supplemental Content

Support Center